Advertisement
UK markets closed

  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     

  • HANG SENG

    18,491.62
    +15.70 (+0.08%)
     

  • CRUDE OIL

    78.41
    +0.30 (+0.38%)
     

  • GOLD FUTURES

    2,320.20
    +11.60 (+0.50%)
     

  • DOW

    38,675.68
    +449.98 (+1.18%)
     

  • Bitcoin GBP

    50,821.41
    +392.35 (+0.78%)
     

  • CMC Crypto 200

    1,328.07
    +51.09 (+4.00%)
     

  • NASDAQ Composite

    16,156.33
    +315.33 (+1.99%)
     

  • UK FTSE All Share

    4,469.09
    +22.94 (+0.52%)
     
BRANDS:

Meet one of the UK’s largest unknown start-ups

Video editing platform Veed has grown to 10 million users

BUZZ-Scancell: drug problem spurs worst day in 3 yrs

Reuters - UK Focus

** Drug developer Scancell's shares down 27 pct, worst day in nearly three years, after suspends dosing in a cancer clinical trial because of quality problems with its immunotherapy treatment SCIB1

** Co says current supplies of drug no longer meet original specification and are no longer suitable for further use

** The suspension affects 8 patients in a clinical trial, co says

** Shares (Berlin: DI6.BE - news) at 6-mth lows, with more than 10x their 30-day avg vols gone through in the first half hour of trade (venkateshasoumithri.mamidipudi.thomsonreuters.com@reuters.net)